BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.12 | $76,156 | -$443,750 |
| 2026 Q1 | -0.22 | $22,842 | -$148,000 |
| 2025 Q4 | -0.53 | $483,760 | $960,085 |
| 2025 Q3 | -0.39 | $3M | -$1M |
| 2025 Q2 | -0.34 | $2M | -$759,366 |
| 2025 Q1 | -0.35 | $2M | -$833,124 |
| 2024 Q4 |
| -0.19 |
| $3M |
| -$58,340 |
| 2024 Q3 | -0.75 | $3M | -$2M |